“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

The study supports prior research that found the same thing.

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of medicine ... specifically signal to your brain to feel less hungry, making it less likely ...

Middle-aged folks and seniors whose weed use lands them in the hospital are at higher risk for developing dementia within a ...

It’s been called “Ozempic for alcohol,” for its ability to reduce cravings, yet most people struggling with addiction have ...